Congenital bilateral absence of the vas deferens (CBAVD) is found in most males with cystic fibrosis (CF), but this malformation can be observed without any pulmonary or digestive features. We have analyzed 13 exons of the CF gene in a cohort of 25 CBAVD patients. Among the 50 chromosomes studied, 24 mutations were identified: SF508 (14 cases), Ri 17H (7 cases), Ri 070W (2 cases), 621+1 G-*T (1 case), and A1O67V (1 case). Except for zF508, the most frequent mutations (Rii7H, R1O7OW) were not observed in the CF group (109 patients) studied in our laboratory.
We discuss the significance of these results.
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Congenital bilateral absence of the vas deferens (CBAVD) accounts for 1-2% of male sterility. 4 Moreover, CBAVD is found in most males with cystic fibrosis (CF). For this reason, since 1990, the hypothesis of a nosologic identity between these two disorders has been proposed. group studied in our laboratory. We also analyzed the intron-8 polypyrimidine tract length variants that can affect the phenotype produced by some mutations (6) . Together with these results, we present the identification of a rare mutation in exon 17b. mmol/L.
Materials and Methods

Patients
Detection of Mutations
Total genomic DNA was isolated from the patients' peripheral blood cells and analyzed for mutations in the CFTR gene. Chromosomes were first tested for the presence of the zF508 mutation by heteroduplex formation (7) and by polymerase chain reaction (PCR)-mediated site-directed mutagenesis (8) . The non-SF508 chromosomes were then screened for mutations in 13 exons (2, 3, 4, 7, 10, 11, 12, 14a, 17b, 19, 20, 21 , and 23) by denaturating gradient gel electrophoresis (9, 10) . Computer analysis was performed by using the Melt 87 and SQHTX programs, generously provided by L. Lerman (11). The primers used, the range of denaturant concentration, and the run time are given in Table 1 . Samples displaying a modified migration pat- 
Detection of CFTR lntron-8 Polypyrimidine Tract Length Variants
Samples bearing the R117H mutation were analyzed for the intron-8 splice variants 5T or 7T (6). The oligonucleotides used for amplification were C:
5'TGGGCCATGTGCT'lTPCAAAC 3'; D: 5'CTFCTA-ATGGTGATGACAGCC 3'. The PCR product was purified on a Chromaspin-100 column (Clontech, Palo Alto, CA) and sequenced with the PCR primers.
Results
Different genotypes are listed in Table 2 , in which two patients' cohorts are compared:
one composed of 25 CBAVD and the other of 109 CF cases studied in our laboratory.
Among the 50 chromosomes studied, 24 mutations (48%) were identified as follows: 13 patients were heterozygous for the SF508 deletion (52%), 6 of whom were compound heterozygous for the SF508 and missense mutations such as R117H (3 cases), R1O7OW (2 cases), and a rare mutation designated as A1067V (1 case) recently identified in a CBAVD patient (12); 5 patients had only one identified mutation: R117H (4 cases) and 621+1G-'T (1 case); and 7 patients had no mutation in the 13 studied exons. In the intron-8 splice acceptor site the 7T variant was found in all seven R117H carriers. Consequently, CBAVD patients and their partners should be advised to submit to DNA analysis and to seek genetic counseling.
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